SE8702936L - Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar - Google Patents

Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar

Info

Publication number
SE8702936L
SE8702936L SE8702936A SE8702936A SE8702936L SE 8702936 L SE8702936 L SE 8702936L SE 8702936 A SE8702936 A SE 8702936A SE 8702936 A SE8702936 A SE 8702936A SE 8702936 L SE8702936 L SE 8702936L
Authority
SE
Sweden
Prior art keywords
tioethers
oxabicycloheptan
hydroximic acids
substituted ethers
hydroximic
Prior art date
Application number
SE8702936A
Other languages
English (en)
Swedish (sv)
Other versions
SE8702936D0 (sv
Inventor
R K Varma
E M Gordon
L M Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8702936D0 publication Critical patent/SE8702936D0/xx
Publication of SE8702936L publication Critical patent/SE8702936L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8702936A 1986-07-23 1987-07-22 Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar SE8702936L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (2)

Publication Number Publication Date
SE8702936D0 SE8702936D0 (sv) 1987-07-22
SE8702936L true SE8702936L (sv) 1988-04-07

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702936A SE8702936L (sv) 1986-07-23 1987-07-22 Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar

Country Status (29)

Country Link
US (1) US4673685A (xx)
JP (1) JP2557894B2 (xx)
KR (1) KR950010596B1 (xx)
AT (1) AT397094B (xx)
AU (1) AU599384B2 (xx)
BE (1) BE1000141A3 (xx)
CA (1) CA1292003C (xx)
CH (1) CH674010A5 (xx)
DD (1) DD263990A5 (xx)
DE (1) DE3724152A1 (xx)
DK (1) DK383587A (xx)
ES (1) ES2006784A6 (xx)
FI (1) FI873207A (xx)
FR (1) FR2601953B1 (xx)
GB (1) GB2192882B (xx)
GR (1) GR871147B (xx)
HU (1) HU198495B (xx)
IE (1) IE60487B1 (xx)
IL (1) IL82919A0 (xx)
IT (1) IT1222054B (xx)
LU (1) LU86949A1 (xx)
NL (1) NL8701742A (xx)
NO (1) NO168359C (xx)
NZ (1) NZ220677A (xx)
PH (1) PH23711A (xx)
PT (1) PT85381B (xx)
SE (1) SE8702936L (xx)
YU (1) YU46321B (xx)
ZA (1) ZA874255B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
WO1980001381A1 (en) * 1979-01-05 1980-07-10 R Jones Substituted bicyclo (2,2,1) heptanes and hept-2-enes
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA814307B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
WO1983002273A1 (en) * 1981-12-23 1983-07-07 Jones, Robert, Leslie Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
NO168359C (no) 1992-02-12
NL8701742A (nl) 1988-02-16
AU7444887A (en) 1988-01-28
GB2192882B (en) 1990-05-09
IE60487B1 (en) 1994-07-27
FR2601953B1 (fr) 1990-11-16
DK383587A (da) 1988-01-24
IT8721328A0 (it) 1987-07-16
US4673685A (en) 1987-06-16
YU138187A (en) 1988-12-31
FR2601953A1 (fr) 1988-01-29
PT85381A (en) 1987-08-01
DD263990A5 (de) 1989-01-18
GR871147B (en) 1987-12-04
JPS6335576A (ja) 1988-02-16
BE1000141A3 (fr) 1988-05-03
NO168359B (no) 1991-11-04
PT85381B (pt) 1990-04-30
IT1222054B (it) 1990-08-31
AU599384B2 (en) 1990-07-19
GB2192882A (en) 1988-01-27
PH23711A (en) 1989-09-27
GB8714621D0 (en) 1987-07-29
ATA174887A (de) 1993-06-15
HU198495B (en) 1989-10-30
ZA874255B (en) 1988-02-24
ES2006784A6 (es) 1989-05-16
DK383587D0 (da) 1987-07-22
NZ220677A (en) 1989-12-21
NO873069L (no) 1988-01-25
KR880001660A (ko) 1988-04-25
IL82919A0 (en) 1987-12-20
AT397094B (de) 1994-01-25
JP2557894B2 (ja) 1996-11-27
SE8702936D0 (sv) 1987-07-22
IE871675L (en) 1988-01-23
FI873207A0 (fi) 1987-07-21
YU46321B (sh) 1993-05-28
KR950010596B1 (ko) 1995-09-20
FI873207A (fi) 1988-01-24
CH674010A5 (xx) 1990-04-30
CA1292003C (en) 1991-11-12
DE3724152A1 (de) 1988-02-04
HUT47115A (en) 1989-01-30
NO873069D0 (no) 1987-07-22
LU86949A1 (fr) 1988-02-02

Similar Documents

Publication Publication Date Title
ES2008658A4 (es) Procedimiento de preparacion de monoesteres o diesteres del acido 9,10-dihidro antraceno-11,11-dicarboxilico.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
FI822203A0 (fi) Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel
SE8207302L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
SE8307146D0 (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
SE7903976L (sv) Nya purinderivat anvendbara sasom icke-adrenenergiska bronkodilatorer
SE8405123L (sv) Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
SE8702936L (sv) Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
AU562182B2 (en) Bicyclo(4,2,0)1,3,5-octatriene derivatives
AU8143487A (en) New derivatives of 2,2-dimethyl cyclopropane carboxylic acid having a saturated halogenated chain in position 3, the process and the intermediates for their preparation, their use as pesticides and the compositions containing them
JPS5227791A (en) Synthesis of cephalosporins
NO792126L (no) Karbazolderivater.
SE8803765L (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
SE8401280L (sv) Mellanprodukter och forfaraden for framstellning derav
ATE97657T1 (de) Verfahren zur herstellung von propionsaeurederivaten.
ES2060854T3 (es) Procedimiento para la preparacion de acido 2-mercapto-4-metil-1,3-tiazol-5-il-acetico y sus esteres.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
ES502947A0 (es) Procedimiento para la obtencion de esteres de acido dimeta- crilico
DE3662892D1 (en) Bisthiol phosphates, process for their preparation, their use as pesticides and agents therefor
AU529684B2 (en) Organic compounds
FI832818A (fi) Foerfarande foer framstaellning av alfa- substituerade alkylarylketaler.
JPS53141261A (en) Intermediates for prostaglandins and process for their preparation

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702936-9

Effective date: 19920224